| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:307.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medical Physics (R.T.W., Z.L.), University of Wisconsin-Madison; Department of Pediatrics, Division of Cardiology (J.F.S.), Childrens Hospital of Wisconsin, Milwaukee; and Department of Pediatrics, Division of Cardiology (B.D., N.G.), Childrens Memorial Hospital, Chicago, Ill.
Correspondence to Ronald Wakai, PhD, Department of Medical Physics, 1300 University Ave, Madison, WI 53706. E-mail rtwakai{at}wisc.edu
| Abstract |
|---|
|
|
|---|
Methods and Results In contrast to the expectation that reentrant SVT is initiated by spontaneous premature atrial contractions (PACs) and is terminated by spontaneous block, 5 distinct patterns of initiation and 4 patterns of termination were documented, with the most common patterns of initiation involving reentrant PACs. Waveform morphology and timing, including QRS and ventriculoatrial interval, were assessed. This enabled detection of such phenomena as Wolff-Parkinson-White syndrome, QRS aberrancy, and multiple reentrant pathways that were crucial for defining the rhythm patterns. In addition, fMCG actocardiography revealed an unexpectedly strong association between fetal trunk movement and the initiation and termination of SVT, suggesting that autonomic influences play a key role.
Conclusions This study demonstrates that the patterns of initiation and termination of fetal SVT are more diverse than is generally believed and that the most common patterns of initiation involve reentrant PACs. The ability to discern such patterns can help elucidate the underlying mechanisms and guide antiarrhythmic drug therapy. fMCG provides a noninvasive means of analyzing complex tachyarrhythmia in utero, with efficacy approaching that of postnatal electrocardiographic rhythm monitoring.
Key Words: electrophysiology arrhythmia tachycardia
| Introduction |
|---|
|
|
|---|
A shortcoming of present evaluation methods has been the limited ability to perform direct electrophysiological analysis of fetal rhythm in utero. Analysis of fetal rhythm via fetal ECG (fECG) is precluded by the poor quality of surface recordings; however, recently several groups have demonstrated the efficacy of fetal magnetocardiography (fMCG) for this application.25 The fMCG is the magnetic counterpart to the fECG, but it exhibits significantly better signal quality because it is largely unaffected by the high electrical resistance of the fetal skin, which attenuates the fECG and other fetal bioelectric signals.
Fetal SVTs are predominantly reentrant tachycardias, of which the most common type is atrioventricular reentrant tachycardia. Atrioventricular nodal reentrant tachycardia is thought to be rare in the neonate.1,6 Reentrant SVTs are characterized by sudden initiation and termination. It is generally believed that SVT is initiated by a critically timed spontaneous premature atrial contraction (PAC) and is terminated by spontaneous block. The PAC causes delayed antegrade conduction through the AV node with subsequent retrograde conduction through the accessory connection, thus initiating orthodromic reciprocating tachycardia. In this study, we apply fMCG to characterize the electrophysiological, or more precisely magnetophysiological, patterns of initiation and termination of reentrant SVT. We identify 5 distinct patterns of initiation and 4 patterns of termination and implicate fetal movement as an important concomitant.
| Methods |
|---|
|
|
|---|
Study Cohort
The study cohort was comprised of 13 consecutive fetuses diagnosed with SVT (fetal heart rate >200 bpm) at our institutions between May 2001 and June 2002. SVT was defined by 1:1 atrioventricular concordance or contraction sequence, abrupt onset and termination, and minimal heart rate variability. Minimal heart rate variability was defined as confinement of heart rate within a band of 10 bpm for 90% of the time. One fetus that had not received antiarrhythmic medication was in SVT during entire the fMCG recording session, and 4 fetuses that had received a course of antiarrhythmic therapy were in sinus rhythm throughout. Data are presented from the remaining 8 fetuses. Antiarrhythmic drug therapy was begun before fMCG recording for subjects 1, 3, 5, and 8 and subsequent to fMCG recording for subject 2. Subjects 4 and 8 involved twin pregnancies. Subjects 2 and 8 participated in 2 recording sessions; however, for subject 8, data from only the second session are presented, because SVT was incessant during the first session.
fMCG Recording and Analysis
The fMCG studies were performed in the Biomagnetism Laboratory at the University of Wisconsin-Madison in accordance with institutional guidelines. The recordings were made in a magnetically shielded room with a 37-channel biomagnetometer (Magnes, 4D Neuroimaging, Inc). A brief ultrasound examination was performed to guide probe placement.
Typically, 5 to 13 recordings, each of 10-minute duration, were taken from each subject at several different probe positions. The recordings were digitized at 520 Hz and were bandpass filtered from 1 to 80 Hz. Maternal interference was removed using either a matched filter or a spatial filter.7
fMCG actocardiography8 was used to monitor fetal heart rate and fetal activity. This method of actography is based on the high sensitivity of the fMCG signal to the position and orientation of the fetal heart and is therefore specific for fetal trunk movements, which produce prominent episodic variations in signal amplitude that are distinct from abrupt variations attributable to such causes as rhythm changes and aberrant conduction. Actograms were obtained by plotting QRS amplitude as a function of time. QRS amplitude increases when the fetus moves toward the sensor, decreases when it moves farther away, and varies in a more complex manner when fetal orientation changes.
Postnatal Recording
Postnatal 12-lead ECGs were obtained within 24 hours of delivery. Postnatal transesophageal pacing was performed in 2 subjects.
| Results |
|---|
|
|
|---|
|
|
In subject 1, SVT initiated with spontaneous PACs, as exemplified in Figure 1. QRS aberrancy was always prominent at initiation and may have been potentiated by antiarrhythmic drug effect. The termination tracing shows a P wave after the last beat of SVT, implying that termination was attributable to spontaneous antegrade block in the AV node. This was the most commonly observed termination pattern in this study.
|
In subject 2, WPW was present continuously during sinus rhythm, evidenced by short PR interval (83 to 90 ms), prolonged QRS interval (69 to 82 ms), and delta wave presence. The beat that initiated SVT showed abrupt normalization of PR interval and QRS, with no change in PP interval or P-wave morphology (Figure 2). This implied that initiation was attributable to sudden antegrade block of the accessory connection in WPW, which allowed retrograde conduction through the accessory connection and subsequent SVT. VA lengthened during tachycardia when the QRS was aberrantly conducted. This finding supports the presence of an accessory AV connection ipsilateral to the location of the bundle-branch block.
|
In subject 3, who was studied in two sessions on consecutive days, SVT initiated with sinus acceleration (Figure 3). In contrast to initiation by PACs (Figure 1), the change in RR interval was gradual, with the two beats before SVT showing progressive RR shortening. QRS aberrancy was absent at and after initiation. Termination was again attributable to antegrade block. Notice, however, that the first 2 beats of sinus rhythm were preexcited. This marked the beginning of a 40-second period when WPW predominated. At all other times on day 1, WPW was absent. On day 2, initially the fetus was in SVT. After 15 minutes, SVT terminated and sinus rhythm was observed thereafter. Unexpectedly, WPW was present at all times during sinus rhythm on day 2 (Figure 3).
|
Subjects 4 through 8 showed frequent ectopy, compatible with reentrant PACs. The PACs usually had polarity opposite that of the sinus P waves and fixed VA interval similar to that seen during SVT. The PACs resulted in atrial bigeminal and polygeminal rhythms, in which instantaneous fetal heart rate cycled over a wide range in a precise manner. These rhythms alternated with normal sinus rhythm and SVT, resulting in complex heart rate and rhythm tracings. SVT initiated with a reentrant PAC and terminated with spontaneous block; however, subjects 4 and 5, respectively, showed variant patterns, indicative of involvement of multiple retrograde and dual antegrade pathways.
In subject 4, atrial polygeminy with blocked PACs was present
90% of the time. VA of the PACs was 167 to 173 ms, but during tachycardia, VA was 210 ms, implying the existence of 2 distinct reentry pathways. Normal sinus rhythm was present less than 4% of the time. Despite this, 4 of the 5 episodes of SVT initiated from sinus rhythm, because the rhythm converted from polygeminal to sinus rhythm just before SVT. In all cases, SVT initiated with a reentrant PAC (Figure 4). Thus, reentrant PACs in sinus rhythm were highly effective in initiating SVT, whereas reentrant PACs in atrial polygeminy were ineffective. The initiating PAC and the next atrial beat had short VA, but all succeeding atrial beats had longer VA, until SVT terminated by antegrade block of an atrial beat with short VA (Figure 4). This implies that the faster reentry pathway was used to initiate and to terminate SVT and that the slower one was used to sustain SVT. The termination pattern, as well as the initiation pattern, was therefore different compared with other subjects. Even though termination resulted from spontaneous block, the critical event was a transition from the slow to the fast reentry pathway.
|
Subject 5 showed a unique termination pattern. Termination was attributable to spontaneous block in the AV node, but the last RR interval of SVT was always short, and often several cycles of a long-short sequence were seen at termination (Figure 5). These variations in RR were attributable almost entirely to variations in AV, with VA remaining constant, and were preceded by gradual deceleration of ventricular rate. This patternventricular deceleration, followed by AV oscillationswas sometimes seen during SVT without causing termination (Figure 6, bottom tracing at 175 seconds). These data strongly suggest the existence of dual antegrade AV nodal pathways as well as a single retrograde connection.
|
|
fMCG actocardiography revealed a remarkably strong association between fetal trunk movements and the initiation and termination of SVT (Figure 6). Although fetal movement was present only 10% to 25% of the time, the percentage of rhythm transitions occurring during episodes of fetal movement was
80%. Even when transitions did not coincide with fetal movement, they occurred during periods when the fetus was generally active. In subjects 2, 4, 6, and 7, the mean duration of SVT episodes was relatively brief and the fetus was active throughout SVT. In subjects 1, 3, 5, and 8, the episodes of SVT were much longer. The fetus was sometimes quiescent during SVT but became active around the time of SVT initiation and termination. In subjects 4 through 7, the heart rate tracings were dominated by large, regular oscillations attributable to reentrant PACs. In subject 4, the presence of sinus rhythm, as well as the initiation and termination of SVT, was associated with fetal movement, even when sinus rhythm was not followed by initiation of SVT.
The fMCG recordings showed good agreement with the postnatal ECG, shown in the lower panels of Figure 1 through 3. Fetuses 4 through 8 remain in utero. Concordance of SVT mechanisms was verified. All postnatal subjects showed fMCGs and postnatal ECGs consistent with atrioventricular reentrant tachycardia. WPW was confirmed postnatally in subject 2; however, it was not seen in subject 3, who showed only intermittent WPW in utero.
| Discussion |
|---|
|
|
|---|
The characteristics of SVT in the fetus mirror those defined by classic electrophysiological and Holter monitor analysis in the neonate. These similarities include the following: (1) a high incidence of accessory AV connections as opposed to AV node reentry SVT; (2) presence of both concealed (or unidirectional) and manifest preexcitation; (3) presence of prolongation of VA conduction in association with aberrant QRS conduction during SVT; and (4) an association of SVT onset with prolonged AV conduction and subsequent reentry. In addition to these characteristics, the natural history of WPW in the fetus also seemed to mimic that seen in the neonate with the gradual intermittency or loss of preexcitation over time.
To our knowledge, no similar prior studies of the initiation and termination patterns of SVT have been performed in the fetus. The data presented here are valuable not only because they comprise the first fetal electrophysiological data but also because they represent natural initiation and termination. Much of the prior neonatal data comes from artificial SVT initiation using extrastimulus testing, ie, transesophageal pacing. However, as shown in this study, formation of a spontaneous PAC is only one of the ways in which SVT can initiate. The ability to discern natural patterns of initiation, as was demonstrated here, may be useful clinically, because certain drugs are more effective for suppression of spontaneous ectopy, for altering antegrade or retrograde conduction, or for treatment of particular types of tachycardia.
An important aspect of electrical rhythm monitoring is assessment of waveform morphology. This allows detection of such phenomena as WPW and QRS aberrancy, which cannot be seen with ultrasound. WPW was present in 2 of 8 subjects, and QRS aberrancy was common at the initiation of or within the first several beats of tachycardia in 4 of 8 subjects. Generally, aberrancy is associated with rapid rate or shorter coupling intervals and is a distinguishing feature of SVT onset. Its absence in the fetus whose SVT initiated with sinus acceleration suggests adaptation to shorter coupling. QRS aberrancy has been shown to have importance for clinical SVT assessment. Goldstein et al10 demonstrated that QRS aberrancy is more common in the sicker infants with SVT. Aberrancy can also help lateralize the accessory connections, because in infants it is strongly associated with left-sided accessory connections. Finally, in fetuses being treated with medication, the presence of QRS aberrancy may reflect drug effect.
In the normal fetus, atrial ectopy is common, with an incidence of 1% to 3%. Approximately 1:200 fetuses with atrial ectopy are at risk for the development of SVT in utero or at up to 1 month of age.11 Frequent ectopy was present in 4 of our subjects and could be distinguished as reentrant PACs versus spontaneous multifocal atrial activations on the basis of single atrial morphology and short, fixed coupling interval.
Evidence was seen for the existence of multiple retrograde and antegrade pathways and their involvement in the initiation and termination of SVT. The presence of multiple pathways is an additional risk factor for SVT. This suggests that fMCG can help identify which fetuses with ectopy are at higher risk for SVT on the basis of type of ectopy and number of reentrant pathways.
The underlying factors that trigger initiation and termination of SVT are largely unknown. The strong association between fetal trunk movement and the initiation and termination of SVT, revealed here by fMCG actocardiography, suggests that autonomic factors play a key role. Generally, fetal body movements are accompanied by increased sympathetic and decreased vagal tone.12 Such changes in autonomic activity are compatible with the association seen here between fetal body movements and patterns of SVT initiation involving PACs and sinus acceleration.
More difficult to understand is the initiation of SVT attributable to block of the accessory connection in WPW. Although it is well known that exercise can cause sudden, rate-dependent block of the accessory connection in adult WPW patients, this explanation is unlikely in our patient, because sinus acceleration was absent at initiation. An alternative explanation is that block was attributable to concealed reentry involving one or more accessory connections. This is supported by the observation that this patient resembled patients 4 through 8 in the frequency of SVT episodes. We speculate that increased sympathetic activity attributable to fetal movement enhanced concealed retrograde conduction through alternate pathways. Another possible explanation is concealed reentry within the atrium.
fMCG provides an effective, noninvasive means of analyzing complex fetal rhythm patterns that potentially can overcome some of the shortcomings of ultrasound. It can aid in the differential diagnosis of ventricular tachycardia (VT) with 1:1 conduction versus SVT and of VT with AV dissociation versus junctional ectopic tachycardia. We recently studied one patient with VT and 1:1 conduction who was classified correctly on the basis of fMCG. In addition to rhythm assessment, the ability of fMCG to provide actocardiogram tracings was shown here to be very valuable. fMCG holds much promise as a clinical tool, but presently the technology is expensive and is available in only a few centers in the United States and abroad. Patients traveled as far as 150 miles to participate in the study. We believe that there is need to make this technique more widely available.
In conclusion, we have demonstrated the ability of fMCG to discern natural patterns of initiation and termination of fetal SVT. The data show that these patterns are much more diverse than previously believed and that the most common initiation pattern involves reentrant PACs. This capability can be exploited to better classify and treat fetal SVT. Other forms of serious fetal arrhythmias can be investigated in a similar manner. With additional development, the efficacy of fMCG for assessment of rhythm in utero may rival that of postnatal electrocardiographic monitoring.
| Acknowledgments |
|---|
Received August 1, 2002; revision received September 27, 2002; accepted September 30, 2002.
| References |
|---|
|
|
|---|
2. Van Leeuwen P, Hailer B, Bade W, et al. Magnetocardiography in the diagnosis of fetal arrhythmia. Br J Obstet Gynaecol. 1999; 106: 12001208.[Medline] [Order article via Infotrieve]
3. Hamada H, Horigome H, Asaka M, et al. Prenatal diagnosis of long QT syndrome using fetal magnetocardiography. Prenatal Diagnosis. 1999; 19: 677680.[CrossRef][Medline] [Order article via Infotrieve]
4. Wakai RT, Leuthold AC, Cripe L, et al. Assessment of fetal rhythm in congenital complete heart block by magnetocardiography. PACE. 2000; 23: 10471050.
5. Menendez T, Achenbach S, Beinder E, et al. Usefulness of magnetocardiography for the investigation of fetal arrhythmias. Am J Cardiol. 2001; 88: 334336.[CrossRef][Medline] [Order article via Infotrieve]
6. Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992; 69: 10281032.[CrossRef][Medline] [Order article via Infotrieve]
7. Chen M, Wakai RT, VanVeen B. Eigenvector-based spatial filtering of fetal biomagnetic signals. J Perinat Med. 2001; 29: 486496.[CrossRef][Medline] [Order article via Infotrieve]
8. Zhao H, Wakai RT. Simultaneity of fetal heart rate accelerations and fetal trunk movements determined by fetal magnetocardiogram actocardiography. Phys Med Biol. 2002; 47: 839846.[CrossRef][Medline] [Order article via Infotrieve]
9. Dunnigan A, Benditt DG, Benson DW Jr. Modes of onset ("initiating events") for paroxysmal atrial tachycardia in infants and children. Am J Cardiol. 1986; 57: 12801287.[CrossRef][Medline] [Order article via Infotrieve]
10. Goldstein M, Dunnigan A, Milstein S, et al. Bundle branch block during orthodromic reciprocating tachycardia onset in infants. Am J Cardiol. 1989; 63: 301306.[CrossRef][Medline] [Order article via Infotrieve]
11. Copel JA, Liang RI, Demasio K, et al. The clinical significance of the irregular fetal heart rhythm. Am J Obstet Gynecol. 2000; 182: 813817.[CrossRef][Medline] [Order article via Infotrieve]
12. Timor-Tritsch IE, Dierker LJ, Zador I, et al. Fetal movements associated with fetal heart rate accelerations and decelerations. Am J Obstet Gynecol. 1978; 131: 276280.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. S Carvalho, F. Prefumo, V. Ciardelli, S. Sairam, A. Bhide, and E. A Shinebourne Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein Heart, November 1, 2007; 93(11): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Nii, R M Hamilton, L Fenwick, J C P Kingdom, K S Roman, and E T Jaeggi Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography Heart, December 1, 2006; 92(12): 1831 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Smith, P. Langley, P. van Leeuwen, B. Hailer, L. Trahms, U. Steinhoff, J. P. Bourke, and A. Murray Comparison of magnetocardiography and electrocardiography: a study of automatic measurement of dispersion of ventricular repolarization Europace, October 1, 2006; 8(10): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. F. Strasburger, B. F. Cuneo, N. L. Gotteiner, and R. T. Wakai Giant Fetal Magnetocardiogram P Waves in Congenital Atrioventricular Block: A Marker of Cardiovascular Compensation? Circulation, October 12, 2004; 110(15): 2097 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Strasburger, B. F. Cuneo, M. M. Michon, N. L. Gotteiner, B. J. Deal, S. N. McGregor, M. A. Oudijk, E. J. Meijboom, L. Feinkind, M. Hussey, et al. Amiodarone Therapy for Drug-Refractory Fetal Tachycardia Circulation, January 27, 2004; 109(3): 375 - 379. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |